Alpha-synuclein (aSyn) protein levels are sufficient to drive Parkinson's disease (PD) and other synucleinopathies. Despite the biomedical/therapeutic potential of aSyn protein regulation, little is known about mechanisms that limit/control aSyn levels. Here, we investigate the role of a post-translational modification, N-terminal acetylation, in aSyn neurotoxicity. N-terminal acetylation occurs in all aSyn molecules and has been proposed to determine its lipid binding and aggregation capacities; however, its effect in aSyn stability/neurotoxicity has not been evaluated. We generated N-terminal mutants that alter or block physiological aSyn N-terminal acetylation in wild-type or pathological mutant E46K aSyn versions and confirmed N-terminal acetylation status by mass spectrometry. By optical pulse-labeling in living primary neurons we documented a reduced half-life and accumulation of aSyn N-terminal mutants. To analyze the effect of N-terminal acetylation mutants in neuronal toxicity we took advantage of a neuronal model where aSyn toxicity was scored by longitudinal survival analysis. Salient features of aSyn neurotoxicity were previously investigated with this approach. aSyn-dependent neuronal death was recapitulated either by higher aSyn protein levels in the case of WT aSyn, or by the combined effect of protein levels and enhanced neurotoxicity conveyed by the E46K mutation. aSyn N-terminal mutations decreased E46K aSyn-dependent neuronal death both by reducing protein levels and, importantly, by reducing the intrinsic E46K aSyn toxicity, being the D2P mutant the least toxic. Together, our results illustrate that the N-terminus determines, most likely through its acetylation, aSyn protein levels and toxicity, identifying this modification as a potential therapeutic target. Cox Proportional Hazard analysis, optical pulse-labeling. J o u r n a l P r e -p r o o f Journal Pre-proof
Introduction
Alpha synuclein (aSyn) is a key protein in a group of neurodegenerative diseases known as synucleinopathies that include Parkinson's disease (PD) and dementia with Lewy Bodies (DLB) among others (1) . Predominantly expressed in brain, aSyn is highly abundant in presynaptic terminals (2) (3) (4) (5) where it binds to the lipid membrane of synaptic vesicles (6) (7) . Although its function is not well understood, aSyn could participate in the assembly and distribution of synaptic vesicles (7) (8) and regulate synaptic vesicle trafficking (exocytosis and/or endocytosis) at the synapse (9) . However, aSyn constitutes the major component of abnormal intraneuronal protein aggregates named Lewy Bodies, the neuropathological hallmark of familial and sporadic cases of synucleinopathies. Point mutations, duplications or triplications on the aSyn encoding gene, SNCA, cause familial forms of PD and DLB (10) strongly supporting a toxic effect of abnormally high aSyn protein levels. Moreover, the SNCA gene is one of the strongest risk loci in sporadic forms of PD determined by genome-wide association studies (11) (12) and polymorphisms in the SNCA promoter increase PD susceptibility (13) . Recently, a PD associated risk variant in SNCA gene regulatory elements that increase transcripts levels has been described (14) . Therefore, quantitative alterations of aSyn protein levels are sufficient to drive synucleinopathies but the molecular and cellular mechanisms by which abnormal aSyn levels cause neuronal death are not fully understood yet.
aSyn is post-translationally modified by phosphorylation and ubiquitination among others and its role in normal function and pathology is the subject of intense investigation (15) (16) . In this context, all aSyn molecules are N-terminally acetylated by the N-acetyl transferase B (NatB) complex (17) (18) (19) . N-terminal acetylation is an irreversible co-or post-translational modification based on the addition of an acetyl group to the free alpha-amino group (N-group) of the first amino acid of a protein substrate by an N-terminal acetyltransferase (Nat) complex. In humans, six cotranslational Nats (NatA to NatF) acetylate around 80% of the proteome in a substratespecific manner. Such specificity is mainly driven by the first two amino acids on the polypeptide chain of the substrate (20) . For instance, NatA complex acetylates Ala-, Ser-, Thr-, Val-, Gly-and Cys-N-termini of protein substrates in which the first Methas been removed by methionine aminopeptidases (MetAPs) whereas NatB acetylates the N-terminal Met-of protein substrates starting with Met-Asp, Met-Glu, Met-Asn and Met-Gln (21-23). Recently, a specific post-translational mechanism of actin N-terminal acetylation by NatH (NAA80) has been discovered (24) . dynamic equilibrium with unfolded monomers (38) (39) (40) . Additionally, most studies have been focused to address the effect of N-terminal acetylation on aSyn lipid binding as well as on its aggregation properties (33) (34) (41) (42) (43) (44) where it has been found that inhibits the pathological process of aSyn oligomerization/aggregation. Biochemical studies have also proposed that N-terminal acetylation could mediate aSyn binding to calmodulin (45) , copper ions (46) and, more recently, the interaction with N-linked glycans (47) .
Despite the many possible roles of N-terminal acetylation, its effect in aSyn-dependent neuronal toxicity has not been evaluated yet. We previously generated a neuronal model of synucleinopathies in which we longitudinally tracked living neurons expressing fluorescently tagged aSyn versions. This approach enables the risk of neuronal death as well as predictive factors of neuronal death to be quantitatively determined by Cox regression models (48) (49) (50) (51) (52) (53) . Since neurotoxic protein dynamics has a major relevance in neurodegenerative processes, this approach was adapted to determine the stability of neurotoxic proteins in single living neurons (optical pulse labeling (OPL) method) (54) (55) . The risk of neuronal death induced by WT and pathological mutant versions of aSyn (A30P, E46K and A53T) was quantified. In this model we addressed the contribution of key pathological hallmarks such as aSyn stability and aggregation. Moreover, since the model recapitulated the pathological phosphorylation in serine 129 (P-S129) of aSyn, we identified the neuronal kinase responsible for aSyn phosphorylation (Polo-Like Kinase-2 (PLK2)) and evaluated the contribution of this post-translational modification to neuronal death (56).
Taking advantage of this longitudinal approach, here we have addressed the effect of Nterminal acetylation on aSyn-dependent neuronal toxicity. To that aim, we have tested the effect of N-terminal aSyn mutations that alter physiological aSyn N-terminal acetylation either blocking N-terminal acetylation or turning aSyn into a NatAdependent N-terminal acetylation substrate. Further, we have evaluated the effect of these mutations in aSyn turnover/half-life by OPL as well as in aSyn-dependent neuronal toxicity by longitudinal survival analysis and Cox proportional hazard (CPH) analysis.
Materials and Methods

Plasmids
Alpha-synuclein (aSyn) N-terminal mutants were generated in WT or E46K pathological mutant versions C-terminally tagged with mCherry (Ch) or Dendra2 (Dd) (56) through PCR amplification with the following forward and reverse oligonucleotides:
Untagged aSyn versions were generated in identical expression plasmids to the ones used in this study. Using an untagged WT aSyn version derived from Syn-IRES-GFP (56), N-terminal mutants (D2A, D2P and D2E) were generated by PCR amplification with the aforementioned forward oligonucleotides and the following reverse All plasmids were verified by sequencing.
Neuronal and Cell Cultures, Transfections.
Animal handling was carried out in accordance with European Community Council Directive 2010/63/EC and Spanish legislation (Real Decreto 53/2013, and the protocols were approved by the Ethics Committee of the University of Navarra (051-13 and 038-18). Protocols to establish primary cultures of cortical neurons and maintain human embryonic kidney cells 293 (HEK293) were performed as described elsewhere (56). HeLa cells were maintained with DMEM (Gibco) supplemented with 10% FBS (Gibco) and 1% penicillin-streptomycin (Gibco).
Transfection of Rat Primary Neurons and Cell Lines
Primary cortical neurons were transfected 5 days after plating with Lipofectamine 2000 (Invitrogen) as previously described (56) or calcium phosphate; 1 hour prior transfection neuronal growth medium from neurons growing in a 24-well plate, was replaced by DMEM (Lonza) with 0.001% gentamicin/KY pH 7.4. Meanwhile, the DNA-calcium phosphate mix (per well: DNA mix: 1.5 µg of DNA and 125 mM CaCl 2 (Sigma) and HEPES buffer solution at optimum pH range (6.8-7.2): 137 mM NaCl (Sigma-Aldrich), 5 mM KCl, 0.7 mM Na 2 HPO4*7H 2 O, 7.5 mM D-(+)-Glucose (dextrose) (Sigma) and 21 mM HEPES (Sigma)) was prepared. The DNA-calcium phosphate mix was incubated at room temperature (RT) for 20 min and afterwards 25 µL of the mix was added to each well. Neurons were incubated for 45-60 min, until the appearance of thin and granulate DNA-calcium phosphate precipitate was observed. Subsequently, the medium was replaced with shock solution (50% (V/V) HEPES buffer solution pH 7.4, 10% (V/V) DMEM/KY pH 7.4 and 2% (V/V) DMSO (Sigma)) and immediately washed twice with DMEM/KY and once with DMEM supplemented with 0.001% gentamicin. Finally, neurons were left with neuronal growth media (Neurobasal medium supplemented with 1% FBS, 1% GlutaMAX (Gibco), 2% B27 (Gibco), 0.1 mg/ml gentamycin (Life Technologies, Carlsbad, CA) and 2.5 mg/ml fungizone (Gibco)) and the plate was placed back to the incubator.
HEK293 cells were transfected with DNA-calcium phosphate mix as it has been described (56). HeLa cells were plated in P100 plates 24 h prior transfection to reach 60-70% confluence. One hour before transfection, medium was replaced with DMEM (Gibco) supplemented with 1% penicillin-streptomycin (Gibco) and the plates were placed back to the incubator. Meanwhile, transfection mixture was prepared on Opti-Mem (Gibco) medium (reduced serum with GlutaMax (Gibco) with X-tremeGene HP DNA Transfection Reagent (Roche) and 12.5 µg of the desired plasmid and incubated at RT for 30 min. Afterwards, 662.5 µL of the DNA-XtremeGene mix dissolved in OptiMem medium was added to each well and incubated for 24 h. Finally, the medium was replaced by DMEM, 10% FBS, and 1% penicillin-streptomycin. Cells were placed back to the humidified incubator (37º C and 5% CO 2 ) until immunoprecipitation experiments. 6 48 h after transfection and prior to protein extraction and WB experiments, image acquisition of HEK293 cells plated on six-well plates was performed (see details in section Automated Image Acquisition). After imaging, HEK293 whole cell lysates were collected for total protein extraction and WB as previously described (56). IP experiments were performed 48 h after transfection on HeLa cells. Cells were washed with PBS at RT, scraped and transferred to 15 mL polypropylene tubes and placed on ice. Samples were centrifuged at 300g for 5 min at 4ºC. The supernatant was discarded and the pellet washed with PBS (RT) and centrifuged again at 400g for 5 min, 4ºC. The supernatant was removed with a vacuum pump and the tube was flicked to loosen the pellet before adding 800 µL of lysis buffer per plate (50 mM Tris-HCl (Bio-Rad), 150 mM NaCl (Millipore), 0.05% Triton X-100 (Sigma), 1 mM PMSF (Serva), 0.001 mg/mL aprotinin (Roche), 1 mM sodium orthovanadate (Roche) and 1 mM sodium pyrophosphate (Roche) and placed on a rotary mixer for 30 min at 4ºC. After this, samples were sonicated 3 pulses for 5 seconds (sonicator programmed at 90% duty cycle and an output level of 1) and centrifuged at 4º C, 15,700g during 10 min. The supernatants were collected and transferred to clean 1.5 mL polypropylene tubes and placed on ice. Red fluorescence protein-Trap_M (RFP-Trap_M, Chromotek) (a highquality Red Fluorescence Protein binding protein coupled to magnetic agarose beads) was used to isolate by IP aSynCh and its N-terminal mutant versions (D2ASynCh, D2PSynCh and D2ESynCh). Before using the RFP-Trap_M slurry, it was washed thrice with elution/wash buffer (10 mM Tris-HCl pH 7.4 (Bio-Rad), 150 mM NaCl (Millipore), 0.5 mM EDTA (Sigma) Afterwards, 800 µL of the protein samples were added to the tubes containing the washed RFP-Trap_M beads. Samples were placed on a rotary mixer at 4º C O/N. The following day, samples were placed on the magnetic stand and supernatant was carefully discarded. Samples were removed from the magnetic stand; elution/wash buffer was added and then placed on a rotary mixer for 5 min at 4º C. Subsequently, samples were placed again on the magnetic stand and the supernatant was carefully discarded. Afterwards, two additional washing steps were performed with the elution/wash buffer. Finally, the RFP-Trap_M bound to the proteins of interest was saved at -80º C until mass spectrometry assays. IF experiments on primary cortical neurons were performed as previously described (56).
Mass Spectrometry
Gel bands corresponding to aSyn were stained with Coomassie Brilliant Blue and excised from the gel and the proteins were digested in-gel by covering gel pieces with 12 ng/l proteomics-grade glutamyl C-terminal endopeptidase (Glu-C) (Sigma) and incubated O/N at 37 °C. Digested peptides were concentrated to dryness. False discovery rate was performed using a non-lineal fitting method (58) and displayed results were those reporting a 1% Global false discovery rate or better.
Automated Image Acquisition
Due to the non-proliferative nature of neurons, transient transfections with fluorescent tagged proteins allow us to longitudinally track neurons over long periods of time (56). In this context, primary cortical neurons growing on 24-well plates were placed on a Zeiss Observer Z1 microscope (Zeiss) equipped with a chamber that maintains neurons with a stable 37°C temperature and 5% CO 2 supply. Zen Software System (Zeiss) allows images to be automatically acquired at determined positions with 10x or 20x long distance objectives either in single or multiple channels designating those positions with particulate spatial coordinates. A sequential and automated repetition of a series of tasks (locating a particular neuronal field, automatic focusing, image acquisition and moving to the following non-overlapping neuronal field) allows fast and efficient scanning of multiple neuronal fields per plate. Once the complete set of images has been acquired, the plate is returned back to the incubator until a new image acquisition is required. For a typical survival experiment, 10 or 15 random positions were acquired from 3 or 4 wells per condition with the 10x objective. A template that contains the same initial positions is used until the experiment finishes, following precisely the same neuronal fields. In the case of optical pulse chase labeling experiments (OPL), up to 160 images per condition were acquired with the 20x objective at manually selected positions.
HEK293 cells growing on six-well plates and transfected with single or dual plasmids, 48 h after transfection and prior to protein extraction were subjected to image acquisition (5 or 10 positions per well were imaged with the 10x long distance objective).
Image Processing and Statistics
Fluorescence intensity measurements were performed with MetaMorph Analysis software (Molecular Devices). Measurements were performed in single cells or neurons by marking an area in the soma of each neuron and then subtracting from this measurement the background signal. In the case of measuring fluorescence intensity on different channels, the same selected area was transferred between images corresponding to each channel. GraphPad Prism 5 Software was used to obtain graphs and to perform the following statistical analysis: t-test, Mann-Whitney test, correlation tests, Kruskal-Wallis and Dunn´s post-hoc, one-way Anova and Bonferroni´s post-hoc tests.
For survival experiments, a MATLAB-based semi-automated ad hoc program previously developed (56) was used to determine the survival time of individual neurons. Briefly, at initial time (T1) 20-24 h after transfection, neurons are selected and numbered by the user. Then the program opens the same neuronal field at different experimental points where the user compares it with the previous time. Dead neurons were identified and categorized as uncensored events, whereas those neurons that survive until the experiment ends were categorized as censored events. MATLAB-based semi-automated program saves a print screen of each neuronal field at T1 where individual neurons were identified and selected. So, to determine the effect of protein expression levels in survival experiments, mean fluorescence intensity from each individual tracked neuron was measured at T1 with MetaMorph Analysis software. All data for each individual neuron (protein expression levels, survival time, and censored/uncensored categorization) were exported to Excel and all further survival analysis was performed with STATA 12. The Nelson-Aalen cumulative hazard function was used to plot the differences in the cumulative risk of death among the different experimental groups. These differences were further analyzed with Cox regression analysis as long as a proportional hazard assumption was fulfilled (Shoendfeld residual-based test evaluation or graphical assessment). Since transfection conditions are not controlled at the level of individual neuron, clustered Cox regression analysis of neurons from the same well was performed to improve the accuracy of the test. Additionally, since all experiments were repeated at least thrice and there were one or two 24-well plates per experiment, the variability in the baseline toxicity between experiments was adjusted by stratifying the Cox model for each plate. Wald test was performed to evaluate the interest of interactions between different variables. To analyse longitudinal data from optical pulse labeling (OPL) experiments, specific Matlab-based custom software was designed (56). The user selects each neuron at the initial time and then the program assigns specific coordinates for automated detection of selected neurons at subsequent times, measuring the fluorescence intensity in the green channel. To this end, the image is binarized by applying a threshold and several morphological operations are performed in order to determine the pixels that correspond to each neuron. The centroid of the neuron at a given time is then obtained and used to J o u r n a l P r e -p r o o f ascertain for the presence of the neuron (in the same region) at the following time point. This is possible due to the fact that neurons remain roughly at the same positions throughout the experiment. Additionally, the pixels corresponding to each neuron (obtained from the green channel) are used to calculate the average red fluorescence in the neuron (red channel). From these data the program adjusts the average red fluorescence intensity for every single neuron to an exponential decay over time. In practical terms we perform a logarithmic transformation of the intensity values and apply a linear regression, obtaining the slope (-K) and the coefficient of determination (R 2 ). The half-life (t 1/2 ) is therefore calculated on each neuron with the following equation t 1/2 = -LN(2)/K.
Antibodies
Total aSyn: BD Transduction Laboratories (610786). WB (1:1,000). Total aSyn: Synaptic Systems (128211). IF (1:100). mCherry 1C51: Abcam (ab125096). WB (1:2,000). GAPDH 14C10: Cell Signalling (2118). WB (1:1,000). ECL anti-mouse IgG HRP linked: General Electric Healthcare (NA931VS). WB (1:10,000). ECL anti-rabbit IgG HRP linked: General Electric Healthcare (NA934VS). WB (1:10,000). Alexa Fluor 488 goat anti-mouse IgG: Invitrogen. IF (1:500).
Results
N-terminal mutations affect aSyn stability and protein levels.
To evaluate the role of N-terminal acetylation in aSyn-dependent neuronal toxicity we generated N-terminal aSyn variants, replacing the aspartic residue at position 2 of aSyn by proline (D2P), alanine (D2A) or glutamic (D2E). The D2P mutation prevents Nterminal acetylation (41, 59) , but also favors the removal of the N-terminal methionine residue by aminopeptidases (MetAPs). Quite differently, the D2A mutation enables the N-terminal acetylation by NatA but does not impede N-terminal methionine removal (22) . Finally, the conservative D2E mutation enables N-terminal acetylation by NatB (23) . Mutants were introduced both into a wild-type and into the pathological mutant E46K aSyn variants (which we had identified as a highly neurotoxic aSyn (56)) ( Fig.  1A) bearing at its C-terminus the fluorescent protein mCherry (Ch). Importantly, Ch tagging of aSyn enables the identification and tracking of aSyn-expressing neurons and thereby allows to score protein levels and toxicity by longitudinal survival analysis. Of note, Ch tagging does not affect other aSyn post-translational modifications, such as S129 phosphorylation, or toxicity, as we have previously demonstrated (56). First, we confirmed by mass spectrometry (MS) that these mutations had the anticipated effects in aSyn N-terminal maturation. HeLa cells were transfected with aSyn Nterminal versions (SynCh, D2ASynCh, D2PSynCh and D2ESynCh) and Ch (control). After immunoprecipitation (IP) of the recombinant aSyn proteins with an anti-Ch antibody the composition of their N-terminus was analyzed by MS. For WT SynCh, the sequence Ac-MDVFM was identified with the first Met-being acetylated. As previously reported (41) , the non-acetylated sequence PVFM with the first Metremoved was identified for mutant D2PSynCh. For mutant D2ASynCh the sequence Ac-AVFM was identified where the first Met-was removed and the Ala-was J o u r n a l P r e -p r o o f acetylated. Finally, for mutant D2ESynCh the sequence Ac-MEVFM acetylated in the first Met-was identified ( Fig. S1 and Tables S1-S5). Therefore, all mutant proteins displayed the anticipated N-terminal modifications. The N-terminal peptides are listed in Table S5 , showing that all characterized peptides from aSyn WT and D2A and D2E mutants were acetylated while only non-acetylated forms were found in D2P mutant. Interestingly, these mutations within the N-terminus of aSyn led to significant changes in protein steady-state levels. In HEK293 transfected cells with D2ASynCh and D2PSynCh plasmids a decrease in Ch fluorescence intensity was observed when compared to wild-type SynCh. On the contrary, the conservative mutation D2E did not display such reduction (Fig. 1B) . Fluorescence intensity from Ch-tagged aSyn versions constitutes a surrogate for total protein levels ( Fig. 1C ) (56); still, these differences in protein levels were also documented by Western Blot (WB) (Fig. 1D ). As described above, N-terminal acetylation has been found to favour protein-protein interactions or determine protein turnover. In the budding yeast Saccharomyces cerevisiae the N-terminal acetylated alanine constitutes an acetylated degradation signal ( Ac N-degron) targeting nascent proteins to proteasomal degradation as soon as they are synthesized (Ac/N-end rule pathway). Only if the nascent protein folds or establishes interactions with binding partners quickly enough to make the Ac N-degron inaccessible the protein would avoid degradation (30) (31) . Therefore, the decrease in protein levels J o u r n a l P r e -p r o o f observed with D2A mutation could be explained by the Ac/N-end rule pathway, in this case in mammalian cells. Interestingly, and in contrast to an earlier report (41) , our data indicated that mutation D2P also yields decreased aSyn protein levels. To further test whether mutant D2P decreased aSyn accumulation by altering protein stability we measured its half-life in neurons by optical pulse chase labelling (OPL) experiments. By substituting the Ch fluorescent C-terminal tag by the photoconvertible fluorescent protein Dendra2 (Dd) (60) the decay of aSyn can be measured in single neurons by neuronal tracking with automated microscopy (54) . Dd protein (or a Dd-tagged protein) expressed in cells or neurons emits green fluorescence but exposition to a pulse of blue light changes its conformation and its emission spectra, such that it then emits red fluorescence ( Fig. 2A) . Tracking photoconverted individual neurons over time enables simultaneous monitoring of green and red fluorescence intensity changes. The red fluorescence intensity (RFI) observed after a pulse of blue light decreases as the photoconverted protein pool is targeted to degradation; this decrease typically follows an exponential decay over time, thereby documenting protein degradation (Fig. 2B ). Logarithmic transformation of RFI data and linear regression analysis enables half-life estimation of Dd-tagged proteins in individual neurons (Fig. 2C ). Importantly, this approach overcomes the use of radioactivity and/or translational inhibitors (e.g. cycloheximide) that are toxic to cells and neurons and allow us to determine protein half-life in living neurons. Using this methodology we previously calculated that the half-life of aSyn was around 47 hours (h) and that the pathological mutation E46K did not affect significantly its turnover (56).
J o u r n a l P r e -p r o o f
To test the effect of D2P mutation in the half-life of WT and E46K aSyn versions, Dd-tagged versions of the aSyn N-terminal mutations were generated. As observed in Ch-tagged versions, D2P mutation reduced aSyn protein levels. Fluorescence intensity analysis of individual HEK293 cells co-transfected with Dd-tagged aSyn versions and Ch documented a decrease in Dd/Ch ratio in cells expressing aSyn D2P mutation (Fig.  2D ). Lower D2P aSyn protein levels were also observed in protein extracts from the same cells by WB analysis (Fig. 2E ) (of note, untagged D2A and D2P N-terminal mutants also decreased aSyn protein levels (Fig. S2) ). Finally, a similar decrease in fluorescence intensity was obtained when D2P mutant versions were transfected in primary cortical neurons, both in WT and E46K versions (Fig. 2F ). Therefore, neurons expressing Dd-tagged aSyn (WT and E46K) and their D2P mutant versions were subjected to OPL. aSyn half-life was estimated from data obtained from single neurons where RFI decrease fitted an optimal exponential decay (coefficient of determination of R 2 >0.7 and R 2 >0.9; approximately 96% and 78% of total neurons respectively). In both cases D2P mutant displayed a shorter half-life (8 hours) (Fig. 2G ). The effect of D2P mutation on aSyn stability was also assessed in neurons expressing E46K aSyn pathological mutant. Analysis of neuronal data with a coefficient of determination R 2 >0.7 (92% of total neurons) documented a decrease in E46K aSyn half-life by presence of the D2P mutation (5 hours) (Fig. 2H ). The same tendency was observed with R 2 >0.9 (65% of total neurons). Given that the D2P mutation decreased aSyn protein steady-state levels, we tested whether the half-life measurements could depend on the initial amount of photoconverted protein (initial RFI values (RFI 0 )). Indeed, RFI 0 values did not correlate with the estimated half-life for each individual neuron (Fig.  S3A ), so we could rule out that possibility. As expected, a decrease in aSyn half-life was also observed for mutant D2A (Fig. S3B) . Altogether, these evidences indicate that D2P N-terminal mutation decreases aSyn stability contributing to a reduction in protein accumulation, and may suggest that N-terminal acetylation contributes to aSyn protein stability. 
aSyn protein levels and pathogenic mutations determine differently the risk of neuronal death
J o u r n a l P r e -p r o o f
Next, we analyzed the effect of aSyn N-terminal mutations on neuronal survival. The abnormal increase of aSyn protein levels by mutations and polymorphisms is sufficient to trigger neuronal death and cause PD and other synucleinopathies. Since the Nterminal mutations D2A and D2P had a strong effect on aSyn protein stability/accumulation when expressed in cells and neurons we anticipated that they should modulate aSyn toxicity. To test this hypothesis, we first analyzed if our experimental system could recapitulate the importance of aSyn protein levels in neuronal survival. Rat cortical primary neurons were transfected with SynCh, E46KSynCh and Ch as basal control of toxicity. Neurons were longitudinally tracked with automated microscopy (Fig. 3A) . For each individual neuron, Ch fluorescence intensity at 24 hours post-transfection (as surrogate of protein levels) and survival time were estimated (Fig. S4 ). As previously reported (56), aSyn (WT and E46K pathological mutant) increased the risk of neuronal death compared to Ch expression. E46K mutant displayed the highest toxicity ( Fig. 3B ) that was not associated to overall protein levels differences between WT and E46K aSyn neuronal groups (Fig. 3C ). Hazard ratio (HR) coefficients for each aSyn version relative to control (Ch) were estimated by Cox Proportional Hazard (CPH) analysis ( Table 1) .
Given the relevance of aSyn protein levels in neuronal death, we further analyzed whether there was a relationship between aSyn levels on each individual neuron and its survival time. Protein expression levels followed a heterogeneous distribution pattern in the three neuronal populations (Ch, SynCh, E46KSynCh) analyzed. Based on the estimated median for each population (Fig. 3D ), high expression (HE) and low expression (LE) neuronal groups were established (HE; neurons with protein levels >median, LE; neurons with protein levels <median). Of note, the medians for SynCh and E46KSynCh populations were similar. Then, the risk of neuronal death was compared between HE and LE groups in the different populations. HE groups (both in WT and E46K aSyn expressing neurons) showed a significant increase in the risk of neuronal death. There was no difference, however, between HE and LE groups of neurons expressing the control protein (Ch). Further quantitative analysis by CPH analysis, including protein levels as independent variable for each group (Ch, SynCh, and E46KSynCh) (Table S6 ) confirmed that WT and E46K aSyn protein levels significantly predict neuronal death whereas Ch levels did not. To address how much of the aSyn toxicity observed can be attributed to protein levels we further estimated the risk of death of WT and E46K aSyn expressing neurons (variable Group) in a CPH model adjusted by protein levels (variable Prot. Levels) ( Table 2 ). Interestingly, once the effect of protein levels on each group was removed, E46K mutant aSyn still had a significant toxicity whereas WT aSyn did not ( Table 2 ). These results indicated that our model recapitulates the influence of aSyn protein levels as a strong risk factor for neuronal death. Moreover, WT aSyn toxicity is mainly predicted by protein levels whereas E46K aSyn toxicity results from the combined effect of a gain of toxicity caused by the pathological mutation and protein levels. Table 1 
. CPH analysis for group effect on neuronal survival
Ha za rd Ratio (HR) estima ti on for ea ch group (Ch a s reference group). Da ta from 7 i ndependent experiments (12 total plates). Standard Error (Std. Err.) a djusted for cl usters (wells) a nd data stratified by pl a te. CI; Confi dence Interva l .
Table 2. CPH analysis for group and protein levels effect on neuronal survival
Ha za rd Ratio (HR); i n the ca se of Prot. Levels, HR es timation was performed for each uni t of protei n l evel s . n, number of neurons; #, i nteraction. Data from 7 i ndependent experi ments (12 tota l pl a tes ). Sta nda rd Error (Std. Err.) a djus ted for cl us ters (wells) a nd data s tratified by plate. CI; Confidence Interval. A s ignificant i nteraction between va ri a bl es Group a nd Prot. Levels (Wa l d tes t, P<0.001) wa s found.
N-terminal mutants affect differently aSyn-dependent neuronal toxicity.
Once the contribution of protein levels and E46K mutations to neuronal death was established, we scored the effect of N-terminal mutations (D2A, D2P and D2E) in aSyndependent neuronal toxicity. Longitudinally tracked cortical primary neurons transfected with Ch-tagged aSyn versions (WT and E46K pathological mutant) and its N-terminal mutants (D2A, D2P and D2E) were analyzed as described above. D2A and D2P mutant-expressing neurons exhibited lower aSyn protein levels (Fig. 4A, 4B) whereas D2E mutant aSyn displayed protein levels comparable to WT and E46K aSyn original versions (Fig. 4C) . In spite of the decrease in protein levels, only the D2P mutation showed a tendency to reduce WT aSyn toxicity (Fig. 4D ). However, when combined with the E46K mutation, both D2A and D2P significantly decreased aSyn- J o u r n a l P r e -p r o o f dependent neuronal toxicity (Fig. 4E ). HR coefficients for each N-terminal mutant version relative to E46KSynCh were calculated by CPH analysis (Table 3 ). Next, we evaluated whether the decreased toxicity of D2A/D2P-E46K mutants could be fully explained by the reduction of aSyn protein levels, or if these mutations could also affect the intrinsic neurotoxicity of the protein. aSyn protein levels in each group (D2AE46KSynCh, D2PE46KSynCh, D2EE46KSynCh) significantly predicted neuronal death (Table S7 ). Interestingly, the frequency distribution of protein levels on D2A and D2P-E46K aSyn neuronal populations (Fig.4F) was very similar; yet, neurons expressing D2PE46KSynCh caused a lower risk of death compared to neurons expressing D2AE46KSynCh. Based on the median values of protein accumulation, HE and LE groups were established and the risk of neuronal death was analyzed for each group. Interestingly, both HE and LE groups of D2PE46KSynCh expressing neurons showed a lower risk of death when compared to D2AE46KSynCh (Fig. 4G ). This observation was further confirmed using a CPH model adjusted by protein levels (CPH model including Group (E46KSynCh and its mutants D2A, D2P and D2E) and Prot. Levels as variables ( Table 4) ). In summary, CPH analysis revealed that, after normalization by protein levels, D2A and D2P mutants still exhibited lower toxicity than E46K aSyn. This result indicates that D2A and D2P mutations per se decrease E46K aSyn "intrinsic" toxicity, independently of protein levels. This fact suggests an important role of the N-terminal end in E46K aSyn toxicity since both the removal of the N-terminal Met-and/or the presence of an Ala-or Pro-residues could be involved in this effect. Moreover, since the toxicity of mutant D2P was lower than that of mutant D2A, these findings led us to hypothesize that N-terminal acetylation may have a role in modulating intrinsic toxicity of E46K aSyn. At this point, the status of aSyn (WT and D2A, D2E) N-terminal acetylation in primary neurons should be considered. This status for the different aSyn versions was already determined in transfected HeLa cells by MS ( Fig. S1 and Tables S1-S5). Still, the same approach cannot be applied to transfected primary neurons since transfection efficiency does not allow MS analysis. Naa20 and Naa10 (catalytic subunits of NatB and NatA complexes, respectively) are the proteins that effectively acetylate the different aSyn versions (Naa20 acetylates WT and D2E mutant; Naa10 acetylates D2A mutant). Thus, we analyzed whether Naa20 and Naa10 protein levels differed between HeLa cells and primary neuronal cultures (Fig. S5) . A small decrease in Naa20 protein levels was found in primary neurons compared to HeLa cells. This mild reduction should not impair the quantitative acetylation of NatB substrates that is remarkably robust (it has been demonstrated that reducing NatB protein levels up to 85% causes only a 20% decrease in N-terminal acetylation of its substrates (23)). In the case of Naa10, protein levels in primary neurons where higher than in HeLa cells. Based on these evidences, the acetylated status of aSyn (WT and D2A, D2E) versions in primary neurons should be as expected and to the same extent as in HeLa cells. Finally, D2E mutation behaved in a similar way to E46K aSyn as would be expected for a conservative mutation. J o u r n a l P r e -p r o o f
Discussion
In this study, we provide evidence that N-terminal mutations altering aSyn N-terminal acetylation modulate its toxicity in a neuronal model based on longitudinal tracking of primary neurons transiently expressing aSyn versions. Specifically, we have analyzed two N-terminal mutants; mutant D2A that promotes initial Met-removal and aSyn NatA dependent N-terminal acetylation and mutant D2P that also promotes initial Metcleavage but blocks aSyn N-terminal acetylation. Both mutants caused a decrease in aSyn protein levels when expressed in HEK293 cells or primary neurons and enhance aSyn turnover by OPL. Considering the strong influence of these mutations in aSyn protein levels, we have first analyzed the effect of protein levels on WT and E46K aSyn toxicity with CPH analysis in our longitudinal neuronal model. We have found that WT aSyn toxicity is mainly predicted by protein levels whereas E46K aSyn toxicity resulted from the combined effect of the mutation and protein levels. Finally, the outcome of D2A and D2P mutations in aSyn-dependent neuronal death has been analyzed. D2A and D2P mutations significantly decrease E46K aSyn-dependent toxicity. Interestingly, and once the toxicity of these mutants was normalized by expression levels, D2P mutation was the least toxic. Altogether these results indicate that the first two aSyn N-terminal amino acids modulate its turnover, protein levels and toxicity. Moreover, since the presence (D2A) or absence (D2P) of N-terminal acetylation differentially characterizes these mutants, we hypothesize that N-terminal acetylation modulates the intrinsic toxicity of aSyn.
aSyn protein levels play a determinant role in the neuronal death associated to synucleinopathies. In this regard, the identification of the mechanisms that control or limit aSyn protein levels may lead to novel therapeutic opportunities. Along with this idea it is important to decipher the role of aSyn post-translational modifications as potential modifiers of its levels and toxicity. Biochemical and structural studies have assigned a prominent role of aSyn N-terminal acetylation in stabilizing the -helix of the N-terminal domain, lipid binding and aggregation. However, to the best of our knowledge, this is the first study analyzing the influence of N-terminal acetylation on aSyn neuronal toxicity. Here, we have generated and characterized two N-terminal mutants that affect aSyn natural N-terminal maturation (D2A and D2P) as well as a conservative mutant (D2E). MS analysis confirmed the identity of the first residues and the acetylation status of these mutants. Importantly, mutants D2A and D2P decrease protein aSyn levels. In the case of mutant D2A, our results support the fact that preservation of the acetylated degradation signal ( Ac N-degron) would target aSyn to proteasomal degradation (Ac/N-end rule pathway) similarly to what occurs in S. cerevisiae (30) (31) . Proteins containing an Ac N-degron can remain stable and long lived through immediate intra-molecular interactions or interactions with other molecular partners (31) (32) . However, our results suggest that D2A aSyn mutation would be restricting proper aSyn binding with cellular partners and promoting protein proteasomal degradation.
D2P aSyn mutant was previously described (41) and differences in protein levels with respect to WT aSyn when overexpressed in HEK293 cells were not reported. On the contrary, here we observe that D2P mutant overexpression (in HEK293 cells and neurons) clearly affects aSyn protein levels. This result is supported by the decrease in aSyn half-life induced by D2P mutation detected by OPL in living neurons. There are two potential interpretations of this result; on the one hand, it has been described that a J o u r n a l P r e -p r o o f Pro-in position 2 blocks N-terminal acetylation of the human protein Thymidylate Synthase (TS) enhancing its ubiquitin-independent proteasomal degradation (61-62). A similar effect could be expected for aSyn (33) (34) . On the other hand, the nonphysiological presence of a Pro-in position 1 can confer a gain of instability. In line with this second possibility, Varshavsky and collaborators have recently identified a new branch of the N-end rule pathway in yeast by which the N-terminal Pro-of gluconeogenic enzymes are recognized and degraded (63) . These enzymes contain a Pro-residue at position 1 or 2 and are recognized by the subunit of the GID ubiquitin ligase complex (Gid4 N-recognin) . The presence and activity of the GID ubiquitin ligase complex has been recently shown in humans (64) . However, it has not been demonstrated yet that the GID ubiquitin ligase complex-dependent Pro/N-end rule pathway exists in multicellular eukaryotes. Even though, it is tempting to speculate that a similar mechanism could be responsible for D2P aSyn mutant degradation. Finally, we have also considered the possibility of a potential alteration of the translation initiation since N-terminal mutation D2P exchanges a guanine (G) to a cytosine (C) at position +4 and modifies the optimal flanking sequence for initiation in eukaryotes (65) . If the nucleotides flanking the initiator AUG codon do not provide a suitable context, 43S ribosomes could skip this AUG and resume scanning in a process known as leaky scanning. Indeed, the next ATG in aSyn is located at position +13 in frame, and would generate an aSyn protein lacking the first 4 amino acids. This formal possibility can be ruled out since we have not detected this protein in the MS analysis for the case of mutant D2P (Table S5 ). Therefore, we can conclude that mutant D2P, either by blocking N-terminal acetylation and destabilization of the aSyn N-terminus that may lead to ubiquitin-independent proteasomal degradation or by conferring a gain of instability (e.g. generating a Pro/N-end-rule degron), changes aSyn turnover and decreases its protein levels.
Here, we have taken advantage of our experimental set-up (56) to quantitatively estimate with CPH models the influence of protein levels in aSyn-dependent neuronal death, a key factor in synucleinopathies. Importantly, we have found that protein levels measured approximately 24 hours post-transfection are an important predictive factor of WT and E46K aSyn-dependent toxicity. Moreover, whereas protein levels seem to explain WT aSyn-dependent toxicity, these are not enough to explain E46K dependent toxicity. So, our model faithfully recapitulates the toxic effect of protein levels in neuronal death and indicates that pathological mutant E46K promotes toxicity through additional mechanisms. Precisely, modelling the predictive value of protein levels in neuronal death with CPH has been our starting point to further evaluate the effect of the N-terminal mutations (D2A and D2P) in aSyn toxicity. Specifically, in the case of aSyn E46K pathological mutant, we have discovered a very interesting divergence between mutants D2A and D2P that could imply different mechanisms involved in toxicity. Both mutants decrease E46K-dependent neuronal toxicity. However, once toxicity was normalized by protein levels, mutant D2P emerged as the least toxic. A similar tendency was observed for the effect of D2P mutant in WT aSyn-dependent toxicity although did not achieve statistical significance. A potential explanation of this result could be that small differences in toxicity are easier to observe when using aSyn versions with higher toxicity. Indeed, D2A and D2P mutations decrease WT aSyn-dependent toxicity when using Dd-tagged versions (Fig. S6 ), probably because Dd has a higher basal toxicity than Ch as we previously reported (56).
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These results highlight the importance of the first two amino acids of aSyn to promote neuronal toxicity as well as suggest a potential role of N-terminal acetylation in aSyn toxicity. Our results confirm previous studies in yeast where the first 10 N-terminal amino acids of aSyn played an essential role in aSyn toxicity (66) . In particular, the D2A mutation decreased aSyn-induced yeast toxicity. This effect could be mediated by a change in the membrane-induced aSyn helical folding induced by the first two amino acids (67). Furthermore, our results enable us to hypothesize that N-terminal acetylation stabilizes aSyn perhaps favouring specific interactions (protein-lipid or protein-protein) that underlie neuronal toxicity independently of protein levels. For example, another explanation for the stronger effect of D2P mutant in E46K-dependent toxicity could be also related to the aSyn lipid binding properties. N-terminal acetylation influences aSyn lipid binding (33-34) but interestingly, biochemical and biophysical studies have shown that pathological mutations modulate aSyn binding to lipid membranes too. Indeed, E46K mutation strongly increases aSyn binding to negatively charged membranes and vesicles (68) (69) (70) (71) . Therefore, as potential explanation of our results, blocking N-terminal acetylation would have a stronger effect in E46K than in WT aSyn-dependent toxicity.
In that regard, a previous report indicates that D2P mutation does not alter WT aSyn subcellular localization (41) . However, it would be important to directly address in this context the effect of this mutation in the WT and E46K aSyn lipid binding properties through biochemical experiments.
There is increasing evidence documenting the significance of protein N-terminal acetylation for multiprotein complex formation and function (29, (72) (73) (74) (75) . An interesting example is tropomyosin in which, similarly to aSyn, N-terminal acetylation determines a helical conformation favouring its interaction with tropomodulin. Disruption of the Nterminal helix by removal of the N-terminal acetylation or mutations is pathological (76) . aSyn N-terminal acetylation seems to favour its interaction with calmodulin (45) but the biological role of this interaction is not clear yet. A recent paper has shown that N-terminal acetylation in aSyn mediates the interaction with extracellular N-linked glycans (like the glycoprotein neurexin-1) (47) . This interaction could facilitate the neuronal uptake of extracellular aSyn. Our study highlights the importance of the first two N-terminal amino acids in modulating aSyn-dependent toxicity, potentially via effects on N-terminal acetylation. Further studies will be necessary to identify the specific mechanism by which toxicity is modulated with closer attention to proteinprotein or protein-lipid interactions.
Strategies favouring aSyn turnover constitute potential therapeutic options. Indeed, an interesting genome-wide screen to identify druggable modifiers of aSyn protein levels has been recently described in which genes involved in ER stress/Unfolded Protein Response or lysosome function have been identified (77) . Mutations in the glucocerebrosidase (GBA) gene (involved in lysosomal degradation pathway) represent a significant risk factor for PD (78) and an increase in aSyn protein levels seems to correlate with lower GBA protein activity (79) . Therapies to normalize GBA activity and to decrease aSyn protein levels may also constitute therapeutic approaches to prevent neuronal death in synucleinopathies (80) . Our results underscore the aSyn Nterminal end as a potential therapeutic target. According to this hypothesis the specific targeting of aSyn N-terminal acetylation would decrease aSyn protein levels and toxicity. Inhibitors targeting NatA, NatE and NAA80 have been already developed (81-82) but they are not cell permeable. Moreover, NatB specific inhibitors have not been described yet. Since NatB-dependent N-terminal acetylation inhibition would affect J o u r n a l P r e -p r o o f around 15% of the human proteome, the general inhibition of NatB activity may be toxic; alternatively, a more specific approach would be to selectively target aSyn protein-protein interactions that would depend on N-terminal acetylation and could underlie aSyn toxicity. As an elegant precedent, specific chemical probes targeting Nterminal acetylation-dependent interactions have been already generated (83) showing that protein interactions based on protein N-terminal acetylation are druggable.
Finally, our approach through longitudinal survival analysis allowed us to measure aSyn turnover in neurons, in an experimental system where the influence of other features (such us protein levels) in toxicity can be quantitatively determined. Nevertheless, this model cannot reproduce the complex functional connections among different neuronal subtypes and brain areas with aSyn expression levels closer to the endogenous ones. Future experiments in animal aSyn models will confirm the importance of aSyn Nterminus in neuronal toxicity.
In summary, our results indicate that the first two amino acids of aSyn determine its protein levels and toxicity. We postulate that the presence of N-terminal acetylation contributes to aSyn protein stability and toxicity. Future efforts should be oriented to characterize specific interacting partners underlying aSyn-dependent toxicity as well as to disrupt such interactions as effective therapeutic approaches to synucleinopathies.
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